SILtuximab in Viral ARds (SILVAR) Study

Clinical trial NCT04616586 · TERMINATED

Trial details

NCT number: NCT04616586
Sponsor: RECORDATI GROUP
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Lung Diseases Pneumonia Respiratory Tract Infections Respiratory Tract Disease

Start date: 2020-11-13
Primary completion: 2021-04-01
Enrollment: 555

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.